- Italy
- /
- Healthcare Services
- /
- BIT:EUK
EuKedos Full Year 2024 Earnings: €0.023 loss per share (vs €0.024 profit in FY 2023)
EuKedos (BIT:EUK) Full Year 2024 Results
Key Financial Results
- Revenue: €51.7m (up 4.5% from FY 2023).
- Net loss: €524.0k (down by 194% from €556.0k profit in FY 2023).
- €0.023 loss per share (down from €0.024 profit in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
EuKedos' share price is broadly unchanged from a week ago.
Risk Analysis
You still need to take note of risks, for example - EuKedos has 1 warning sign we think you should be aware of.
Valuation is complex, but we're here to simplify it.
Discover if EuKedos might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About BIT:EUK
Slightly overvalued minimal.
Similar Companies
Market Insights
Community Narratives
